Intended for healthcare professionals

Feature Pharmacovigilance

Risks of reformulation: French patients complain after Merck modifies levothyroxine pills

BMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k714 (Published 16 February 2018) Cite this as: BMJ 2018;360:k714